1,2,4-Triazole-3-thiols as antisecretory agents
    1.
    发明授权
    1,2,4-Triazole-3-thiols as antisecretory agents 失效
    1,2,4-三唑-3-硫醇作为抗分泌剂

    公开(公告)号:US4230715A

    公开(公告)日:1980-10-28

    申请号:US71814

    申请日:1979-09-04

    CPC分类号: C07D209/48 C07D249/12

    摘要: Compounds of the formula ##STR1## wherein R.sub.1 is H or NH.sub.2 ;R.sub.2 is C.sub.1-6 straight or branched chain alkyl; --CH.sub.2 OH; --(CH.sub.2).sub.n --O--(CH.sub.2).sub.m --CH.sub.3 ; phenyl; or --(CH.sub.2).sub.p NH.sub.2 ;n is 1-3;m is 0-3; andp is 1-5;and the pharmaceutically acceptable acid addition salts of those compounds of basic character, have antisecretory activity.

    摘要翻译: 其中R1是H或NH2的式“IMAGE”的化合物; R2是C1-6直链或支链烷基; -CH 2 OH; - (CH 2)n -O-(CH 2)m -CH 3; 苯基; 或 - (CH 2)p NH 2; n为1-3; m为0-3; p为1-5; 和具有基本特征的化合物的药学上可接受的酸加成盐具有抗分泌活性。

    Antisecretory 1,2,4-triazole-3-thiols
    2.
    发明授权
    Antisecretory 1,2,4-triazole-3-thiols 失效
    苯基-1,2,4-三唑-3-硫醇

    公开(公告)号:US4411905A

    公开(公告)日:1983-10-25

    申请号:US273531

    申请日:1981-06-15

    摘要: Compounds of the formula ##STR1## wherein R.sub.1 is H or NH.sub.2 ; R.sub.2 is C.sub.1-6 straight or branched chain alkyl; --CH.sub.2 OH; --(CH.sub.2).sub.n --O--(CH.sub.2).sub.m --CH.sub.3 ; phenyl; or --(CH.sub.2).sub.p NH.sub.2 ;n is 1-3;m is 0-3; andp is 1-5;and the pharmaceutically acceptable acid addition salts of those compounds of basic character,have antisecretory activity.

    摘要翻译: 其中R1是H或NH2的式“IMAGE”的化合物; R2是C1-6直链或支链烷基; -CH 2 OH; - (CH 2)n -O-(CH 2)m -CH 3; 苯基; 或 - (CH 2)p NH 2; n为1-3; m为0-3; p为1-5; 和具有基本特征的化合物的药学上可接受的酸加成盐具有抗分泌活性。

    Alkyloxyamino substituted fluorenones and their use as protein kinase-C
inhibitors
    4.
    发明授权
    Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors 失效
    烷氧基氨基取代的芴酮及其作为蛋白激酶C抑制剂的用途

    公开(公告)号:US6004959A

    公开(公告)日:1999-12-21

    申请号:US844209

    申请日:1997-04-18

    摘要: The present invention describes certain alkyloxyamino-substituted fluorenones which inhibit protein kinase C, as well as pharmaceutical compositions including these compounds and methods of using these compounds to control protein kinase C activity in mammals, including humans. More specifically, the present compounds are useful for the treatment of neoplastic disease states, disorders associated with abnormal blood flow (including hypertension, ischemia, atherosclerosis, coagulation disorders), and inflammatory diseases (including immune disorders, asthma, lung fibrosis, and psoriasis).

    摘要翻译: 本发明描述了抑制蛋白激酶C的某些烷氧基氨基取代的芴酮,以及包括这些化合物的药物组合物以及使用这些化合物控制哺乳动物(包括人)中的蛋白激酶C活性的方法。 更具体地,本发明化合物可用于治疗肿瘤性疾病状态,与异常血流(包括高血压,缺血,动脉粥样硬化,凝血障碍)和炎性疾病(包括免疫疾病,哮喘,肺纤维化和牛皮癣)相关的疾病, 。